New Approaches to Metastatic Hormone Sensitive Prostate Cancer

Описание к видео New Approaches to Metastatic Hormone Sensitive Prostate Cancer

Michael S. Cookson, MD, MMHC, Professor of Urology at the University of Oklahoma, reviews the current treatment landscape of metastatic hormone-sensitive prostate cancer (mHSPC). He goes on to discuss several aspects of the disease, including classifying patients into low or high risk, how to incorporate androgen axis inhibitors with ADT in managing newly diagnosed patients, and how to identify patients who may be candidates for chemotherapy plus ADT in patients with mHSPC.

Комментарии

Информация по комментариям в разработке